Nurix Therapeutics, Inc.

NRIX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001549595

SEC filings (opens in a new tab)

In the last 90 days, Nurix Therapeutics, Inc. insiders filed 0 open-market purchases and 10 sales; 211 institutions reported holding it in 13F filings for Q2 2026, worth $2.84B in total; ARK Invest is the only superinvestor holding it.

Q4 2021 vs. Q3 2021

How the institutions holding Nurix Therapeutics, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021 All holders in Q3 2021

13F holders of NRIX: Q3 2021 compared with Q4 2021
Measure	Q3 2021	Q4 2021	Change
Holders	113	125	+12
Shares	39.5M	40.4M	+946.2K (+2.4%)
Value	$1.18B	$1.17B	−$13.9M (−1.2%)

New holders (24)

Institutions that held Nurix Therapeutics, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to NRIX in Q4 2021
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	136,550	$3.95M	0.02%
Dimensional Fund Advisors LP	116,358	$3.37M	0.00%
Parkman Healthcare Partners LLC	87,824	$2.54M	0.58%
ARK Investment Management LLCSuperinvestorARK Invest	43,947	$1.27M	0.00%
Endurant Capital Management LP	43,542	$1.26M	0.34%
Jefferies Group LLC	41,800	$1.21M	0.02%
Tudor Investment Corp Et Al	24,849	$719.0K	0.01%
Trexquant Investment LP	19,632	$568.0K	0.04%
Squarepoint Ops LLC	16,146	$467.0K	0.00%
Cubist Systematic Strategies, LLC	15,014	$435.0K	0.00%
Los Angeles Capital Management LLC	13,005	$376.0K	0.00%
AlphaCrest Capital Management LLC	9,842	$285.0K	0.01%
Marshall Wace, LLP	9,202	$267.0K	0.00%
EP Wealth Advisors, LLC	8,333	$241.0K	0.01%
Handelsbanken Fonder AB	7,600	$220.0K	0.00%
Schonfeld Strategic Advisors LLC	7,600	$220.0K	0.00%
EDBI Pte Ltd	7,442	$215.0K	0.12%
Dynamic Technology Lab Private Ltd	7,173	$208.0K	0.02%
Allspring Global Investments Holdings, LLC	6,180	$178.0K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	4,047	$117.0K	0.00%
High Net Worth Advisory Group LLC	300	$9.00K	0.00%
Point72 Hong Kong Ltd	265	$8.00K	0.00%
Parallel Advisors, LLC	9	$0	0.00%
Covestor Ltd	11	$0	0.00%

Sold out (12)

Institutions that held Nurix Therapeutics, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of NRIX in Q4 2021
Institution	Shares, Q3 2021	Value, Q3 2021
Foresite Capital Management V, LLC	451,522	$13.5M
Bank of Montreal	164,255	$5.37M
HarbourVest Partners LLC	39,762	$1.19M
Mission Creek Capital Partners, Inc.	39,764	$1.19M
Standard Life Aberdeen plc	19,085	$572.0K
Mass General Brigham, Inc	15,904	$476.0K
ExodusPoint Capital Management, LP	10,747	$322.0K
Walleye Capital LLC	10,546	$316.0K
Blueshift Asset Management, LLC	8,617	$258.0K
Grace Capital	6,727	$190.0K
Penserra Capital Management LLC	1,015	$30.0K
Simplex Trading, LLC	299	$8.00K